Los Angeles, California (CA) Commercial Medical Research Companies

Featured companies
Aftercare Program
300 Ucla Medical Plaza # 2240
Los Angeles CA 90095
(310) 206-3142
Aids Research Alliance
1400 South Grand Avenue # 701
Los Angeles CA 90015
(310) 358-2423
Alzheimer's Association
4221 Wilshire Boulevard # 400
Los Angeles CA 90010
(323) 938-3379
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Cardiovax
10100 Santa Monica Blvd.
Los Angeles CA 90067
(424) 263-6364

Cardiovax
Concern Foundation
1026 South Robertson Boulevard # 300
Los Angeles CA 90035
(310) 360-6106
Farmal LLC
1441 Estlake Avenue # 6316
Los Angeles CA 90089
(323) 865-0612
Neuroenabling Technologies Inc
2200 Linda Flora Drive
Los Angeles CA 90077
(949) 292-9646
Nicodart Inc
149 South Barrington Avenue
Los Angeles CA 90049
(310) 440-2600
Retinoblastoma International
4650 West Sunset Boulevard 88
Los Angeles CA 90027
Stem Cell Sciences LLC
300 South Grand Avenue Floor 8
Los Angeles CA 90071
Ucla Design/Media Arts
240 Charles East Young Drive North
Los Angeles CA 90095
(310) 825-3281
Vasgene Therapeutics Inc
1929 Zonal Avenue
Los Angeles CA 90033
(323) 221-7818
Whereorg has 12 results under Commercial Medical Research Companies in Los Angeles, CA.

Other locations for category Commercial Medical Research


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020